Watch video: https://pages.upwellness.com/uc-ultraliver-vsl03/
SARS-CoV-2 Infection, the Spike Protein and GzmA: Yet Another Carcinogenic Mechanism
There is a serine protease that is actively secreted by cytotoxic immune cells like Natural Killer (NK) cells and T cells called GzmA. Levels of this protein are implicated in the development of cancer.
If we look at SARS-CoV-2 infection, we discover that this protease is markedly elevated compared to healthy controls.
What I find intriguing and important is that GzmA is also found to be expressed significantly in those experiencing Long COVID. This was discovered in a just published study.
So, what we have seen is yet another mechanism which shows that SARS-CoV-2 is almost certainly an oncogenic virus. One observation I have made over the years is how the virus and its Spike Protein can tip the balance of so many different biological processes. It seems to always find a way to push the “bad” lever when it affects a process that can be either beneficial or pathological in the body.
https://wmcresearch.substack.com/p/sars-cov-2-infection-the-spike-protein
We’re “At The Beginning Of The Credit Destruction Cycle”; Ed Dowd Warns
(Tom: Those who do not know history are doomed to repeat it. The economy routinely cycles through periods of boom and bust. If you know where you are in the cycle you are less likely to make decisions that turn out badly.)
Former Wall Street money manager and financial analyst Ed Dowd of PhinanceTechnologies.com warned in September we were at the “Beginning of Panic Rate Cut Cycle.” Since that prediction, the Fed has cut interest rates three times. Looks like Dowd called it correctly.
What is working are precious metals, especially gold. Dowd does not see gold losing its shine anytime soon. Dowd says,
“If we get any kind of credit crisis, gold may get sold temporarily where people sell what they can, but not what they want. Long term, gold looks like it’s going to $10,000 an ounce on the charts by 2030. Everything is conspiring fundamentally and technically to lead us that way. They made gold a Tier 1 asset.
That makes gold money again in the banking system. . .. I would not get scared out of my physical gold position anytime soon.”
https://www.zerohedge.com/markets/were-beginning-credit-destruction-cycle-ed-dowd-warns
Pearl S. Buck
Her manuscript was destroyed by war. Her disabled daughter needed care she couldn’t afford. Her husband controlled every penny. At 35, broke and desperate, she had one last chance—so she wrote a book that changed the world.
Her name was Pearl S. Buck, and she would become the first American woman to win the Nobel Prize in Literature. But first, she had to survive what would break most people.
Born in West Virginia in 1892, Pearl spent just three months in America before her missionary parents carried her to China. She grew up in Zhenjiang on the Yangtze River, speaking Chinese before English, playing with local children with her blonde hair hidden under a hat.
“I did not consider myself a white person in those days,” she later remembered.
She belonged everywhere and nowhere—a feeling that would haunt and define her entire life.
In 1917, she married John Lossing Buck and settled in rural China. Three years later, she gave birth to Carol.
Something was terribly wrong.
Carol couldn’t speak. She had violent tantrums lasting hours. She couldn’t learn basic tasks. Pearl’s husband withdrew completely, leaving her alone with a child whose condition no doctor could explain. Today we know Carol had phenylketonuria—a metabolic disorder causing severe developmental disabilities. In 1920, it was a mystery that felt like a curse.
Her husband controlled every penny of their money, forcing Pearl to beg for an allowance from her own teaching salary. He refused to return to America where Carol might get better care. Pearl realized with crushing clarity: she alone would be responsible for her daughter’s future, and she had no way to provide it.
Then came 1927.
During China’s civil war, the Nanking Incident erupted—a violent uprising that forced Pearl’s family to flee with only the clothes they wore. Soldiers ransacked their home.
In her attic workspace sat the only copy of her first completed novel—years of work destroyed in minutes.
The Red Cross evacuated them to Japan, then to a cramped rental in Shanghai shared with two other families. Her husband returned to work, leaving Pearl alone with the children in poverty.
She was 35. Her marriage was dying. Her daughter needed expensive lifelong care. Her manuscript was ash. She had nothing.
Most people would have surrendered.
Pearl started writing again—not from inspiration, but from desperation. Writing was her only path to financial independence, her only hope for Carol’s future.
She found a trade magazine listing three literary agents and wrote to all three.
Two rejected her immediately: “No American market for stories about China.”
The third, David Lloyd, said yes. He would represent her for 30 years.
In 1929, Pearl took Carol to America to find care. Touring institutions broke her heart—warehouses where disabled children were hidden and forgotten. She finally found the Vineland Training School in New Jersey, a place that seemed humane.
Leaving Carol there was, she said, the hardest thing she ever did.
To afford it, she borrowed money she had no idea how to repay.
Meanwhile, her first novel, East Wind, West Wind, was finally accepted—after 25 rejections. It was the last publisher on her agent’s list. One more rejection and it would have been withdrawn forever.
Pearl returned to China and began writing in a frenzy, driven by financial terror and creative urgency.
Three months later, The Good Earth was finished.
It told the story of Wang Lung, a Chinese farmer, and his wife O-Lan—ordinary people Pearl portrayed as fully human, complex, dignified, worthy of love. In 1930s America, where racism toward Chinese people was rampant, this was revolutionary.
When the Book-of-the-Month Club chose The Good Earth, Pearl received $4,000—enough for years of Carol’s care. She wept. For the first time in her life, she had security.
The book exploded. Nearly 2 million copies sold in the first year. It remained the bestselling novel of both 1931 and 1932. Pearl earned over $100,000 in eighteen months—an astronomical fortune during the Great Depression. She immediately secured $40,000 for Carol’s long-term care.
In 1938, Pearl S. Buck became the first American woman to win the Nobel Prize in Literature.
But her achievement went deeper than a prize. She had humanized Chinese people to Americans who’d been taught to see them as foreign and lesser. She built bridges across cultures through the simple power of storytelling.
She spent the rest of her life fighting for civil rights, women’s rights, and disability rights. She adopted seven mixed-race children. She wrote over 70 books. She founded Welcome House—the first international interracial adoption agency in America.
Pearl died in 1973 at 80. Carol outlived her mother, dying in 1992 at 72, having spent most of her life safely cared for at Vineland—exactly what Pearl had fought so desperately to ensure.
Pearl’s story teaches us something profound: sometimes our greatest work doesn’t come from comfort or privilege. It comes from necessity. From the determination to survive. From the fierce love that makes us refuse to give up.
She didn’t write The Good Earth because she felt inspired. She wrote it because her daughter needed her, and she had no other way forward.
And that desperation—that pure, undiluted love—produced one of the most important American novels of the 20th century.
Pearl S. Buck proved that when we’re fighting for the people we love, we’re capable of changing the world.
MRSA Slayer
In 2015, a group of scientists decided to put an unlikely medieval remedy to the test.
They turned to a 10th-century Anglo-Saxon medical manuscript known as **Bald’s Leechbook**, which described a treatment for eye infections that sounded almost too simple to take seriously. The recipe called for garlic, onion, wine, and oxgall, mixed together in a **brass vessel** and left to sit for **nine nights**. The instructions were precise—so the researchers followed them exactly, down to the type of container used.
Expectations were low. Medieval medicine is often written off as superstition or guesswork. But when the aged mixture was finally tested in the lab, the results stunned everyone.
The salve was applied to **MRSA**, one of the most dangerous antibiotic-resistant bacteria in the modern world. Instead of barely working, the ancient formula wiped out **up to 90 percent** of the bacterial cells—outperforming many contemporary treatments. Even more surprising, none of the ingredients worked nearly as well on their own. The power came from the **exact combination**, prepared exactly as the text described.
The discovery forced scientists to rethink long-held assumptions about early medicine. It suggested that some medieval healers, through observation and experience, had uncovered complex antimicrobial strategies long before modern microbiology existed.
Since then, Bald’s Leechbook has become a symbol of something bigger: the idea that valuable medical knowledge may still be hiding in ancient texts, overlooked simply because of their age.
Sometimes progress doesn’t come from inventing something new, it comes from listening carefully to the past.
Signs from the Earth, Sun, and Planets suggest something BIG is coming
The risk of a megaquake striking Japan is rising as more anomalous earthquake activity continues in an area prone to magnitude 9.0+ earthquakes. Simultaneously, large coronal holes on the Sun have been pumping energy into the Earth continuously now for months, and a very rare planetary alignment will occur early January of 2026, right around when Earth is expected to be experiencing space weather notable for often coinciding perfectly with high-magnitude earthquakes. Will this cosmic convergence cause something big to happen, or will we get lucky? Geophysicist Stefan Burns reports
Click to view the video: https://nexusnewsfeed.com/article/self-sufficiency/signs-from-the-earth-sun-and-planets-suggest-something-big-is-coming/
Prostate Data
(Tom: I saw this ad for a prostate solution. Nearly all the ingredients in this formula are in my Men’s Blend, https://www.healthelicious.com.au/Nutri-Blast-Mens-Blend.html , as well as another 70 for a total of 80 ingredients with the express intention to help the two key aspects of men’s health, the bathroom and the bedroom.)
Three weeks ago, a research paper was published in a European medical journal that should have made headline news…
It didn’t.
No major media coverage. No press releases. No doctors discussing it on morning talk shows.
Instead, something disturbing happened.
The paper was quietly removed from two major medical databases within 72 hours of publication. The lead researcher’s university website was “updated” — her faculty page now scrubbed of any mention of her prostate research. Two American physicians who shared the study on professional forums had their posts deleted for “violating community guidelines.” One received a call from his hospital’s legal department the next morning.
Someone powerful doesn’t want you to see this research.
And after reading what it contains, you’ll understand exactly why.
The study examined prostate tissue samples from 847 men between the ages of 50 and 75.
What they found should change everything we know about prostate problems.
And it should terrify the pharmaceutical companies making $3.2 billion annually from your suffering.
Here’s what the researchers discovered:
In 94% of the tissue samples — nearly every single one — they found massive accumulations of a thick, sticky hormonal residue clogging the microscopic blood vessels inside the prostate.
Not minor buildup. Not trace amounts.
Massive accumulations blocking up to 60% of blood flow to prostate cells.
The researchers had a term for what was happening.
“Prostate Suffocation.”
The prostate was slowly choking from the inside.
This is what’s causing the weak stream that takes forever to start.
The constant urgency that never fully goes away.
The 3am bathroom trips. Then 4am. Then 5am. Night after night after night.
The exhaustion that seeps into everything — work, relationships, the ability to feel joy.
The slow, humiliating feeling of becoming an old man trapped in a body that won’t cooperate.
And here’s the part that should make your blood boil:
This wasn’t new information.
Buried in the study’s citations were references to internal pharmaceutical research dating back decades — proprietary studies conducted by the same companies that manufacture Flomax, Finasteride, and every other prostate drug on the market.
They’ve known about this mechanism for years.
They’ve known that this hormonal residue is the root cause of prostate problems in aging men.
They’ve known that their medications don’t address it — that the drugs they sell simply relax bladder muscles while the underlying suffocation continues unchecked.
They’ve known that 70% of men on their drugs experience bedroom side effects — trading one nightmare for another.
And they’ve kept it quiet.
Because here’s the business problem:
If they created a drug that actually dissolved this residue and restored blood flow, you’d take it for two or three months. Your prostate would heal. Your symptoms would resolve.
And you’d stop paying them.
No more monthly refills. No more $300 prescriptions. No more lifetime of dependency.
A cured patient is a lost customer.
So instead, they sell you medications designed to manage symptoms indefinitely. Drugs that make you comfortable enough to keep taking them, but never address what’s actually wrong.
You stay sick. They stay profitable.
Year after year. Decade after decade.
Meanwhile, men everywhere are living the same quiet nightmare:
Standing over toilets at 3am, exhausted, waiting for a trickle that used to be a stream.
Mapping rest stops before every car trip. Skipping golf outings and poker nights because they can’t sit for three hours without multiple bathroom breaks.
Watching their wives move to the guest room — not out of anger, but exhaustion from being woken up five times a night.
Feeling the pity in her eyes. And knowing that hurts worse than any physical symptom.
Missing grandchildren’s recitals and graduations because they’re trapped in stadium bathrooms, wondering how the hell they became this person.
Turning down the retirement they worked 40 years for — the travel, the fishing trips, the freedom — because their bladder has become their prison warden.
The pharmaceutical industry knows this is happening. They know their drugs don’t fix it.
They don’t care.
But the European researchers didn’t just document the problem.
They documented solutions that actually work.
The second half of their paper examined natural compounds that could dissolve hormonal residue and restore blood flow to prostate tissue.
Compounds used in European medicine for decades — but that American doctors are never trained on. Because drug companies fund medical education. And they don’t teach solutions that would put them out of business.
Here’s what the research showed:
The first compound — Quercetin — reduced prostate inflammation by 46% and dissolved hormonal buildup in tissue samples within just 21 days.
The second — French Maritime Pine Bark Extract — increased blood flow to prostate tissue by 46% and reduced symptoms by 51% over 60 days.
The third — Curcumin with enhanced bioavailability — improved blood vessel function by 37% and slashed inflammatory markers by 44%.
Then Beta-Sitosterol: improved urinary flow rates by 34% and reduced residual urine volume by 24%. Men actually emptying their bladders completely again.
Saw Palmetto Extract reduced DHT levels — the hormone most responsible for residue production — by 30% and decreased nighttime bathroom trips by 25%.
The researchers also documented powerful synergistic effects when these compounds were combined with Pygeum bark, Pumpkin seed extract, Grape seed extract, Lycopene, and Rye pollen extract.
The conclusion was clear: natural compounds that attack the root cause outperformed drugs that just mask symptoms.
This should have been front-page news.
Instead, the study started disappearing.
First from PubMed. Then from Google Scholar search results. Then from the professional forums where physicians share research.
Someone is spending a lot of money to make sure American men never see this.
One person refused to let that happen.
Dr. Michael Thompson had spent 20 years as a board-certified urologist in Austin, Texas. Over 15,000 patients. Countless prescriptions written. Hundreds of surgical referrals.
He believed he was helping people.
Then his own prostate started failing him.
The same nightmare he’d watched thousands of men describe — he was living it. The sleepless nights. The weak stream. The exhaustion that never lifted. The feeling of his body betraying him.
He tried Flomax. The drug he’d prescribed to thousands of desperate men.
Within weeks, he couldn’t perform with his wife.
The “rare” side effect his pharmaceutical training had glossed over? He discovered 70% of men experience it. Seventy percent.
He’d never told his patients that. Because he’d never been told.
His colleagues recommended surgery.
But Dr. Thompson had seen the other side of that equation. The men in diapers. The destroyed marriages. The 40% who needed a second procedure within a decade.
He refused.
Instead, he started digging into research that wasn’t funded by drug companies. Studies from European institutions with no financial ties to American pharmaceutical giants.
That’s when he found the suppressed research.
And everything he thought he knew collapsed.
Twenty years. Fifteen thousand men.
He’d been treating symptoms while the real cause — prostate suffocation — got worse underneath.
The guilt was crushing.
He thought about every man he’d failed. Every prescription that masked a problem instead of solving it. Every patient now living with “rare” side effects that weren’t rare at all.
Dr. Thompson couldn’t unknow what he now knew.
So he walked away.
Left his practice. His $400,000 salary. His reputation. Everything he’d spent two decades building.
And he got to work.
For 18 months, he consulted with European researchers. Analyzed every study on prostate suffocation he could find. Worked with biochemists to develop a formula that addressed the root cause — not just the symptoms.
Based on the research, he created what he called the “Triple-Action Prostate Detox”:
Step 1: Dissolve years of built-up hormonal residue
Step 2: Restore oxygen-rich blood flow to suffocating cells
Step 3: Rebalance hormones to prevent future accumulation
He formulated it with all 10 clinically proven compounds at the exact therapeutic dosages shown to be effective in the European research.
He called it FlowRevive.
Then he tested it on himself.
Day 10: Woke up and realized he’d only gotten up twice. Not five times. Twice.
Week 3: His stream felt different. Stronger. Fuller. He wasn’t standing there for minutes waiting anymore.
Month 1: Slept six straight hours for the first time in years. Woke up confused — then realized he simply didn’t need to pee.
Month 3: Took his wife on a trip they’d been postponing for years. Five-hour flight. Entire vacation without bathroom anxiety. She held his hand on the beach and cried.
“I have my husband back,” she told him.
Word spread quietly. Former patients. Colleagues who trusted him. Desperate men who’d heard whispers about a urologist who’d found something different.
A 62-year-old from Phoenix canceled his surgery after his symptoms virtually disappeared.
A 67-year-old slept 8 hours straight for the first time in a decade. His wife moved back into their bedroom.
A 70-year-old told his wife he felt like the man she’d married 45 years ago. They booked a cruise — something he’d refused to consider for years because of bathroom anxiety.
One man put it simply: “I got my life back. I didn’t realize how much I’d lost until I got it back.”
The pharmaceutical companies will keep trying to bury this research.
They’ll keep paying for studies that support their drugs.
They’ll keep funding the medical education that trains doctors to prescribe their products. They’ll keep pressuring journals to remove anything that threatens their profits.
But they can’t stop you from trying FlowRevive.
They can’t stop you from experiencing what happens when you finally address the root cause instead of masking symptoms.
And they can’t take back your results once you’re sleeping through the night, urinating with a powerful stream, and living without the constant urgency that’s been controlling your life for years.
FlowRevive comes with a 90-day money-back guarantee.
If you don’t experience significant improvement — if you’re not sleeping better, urinating stronger, and feeling like yourself again — you get every penny back.
No questions. No hassles. No risk.
The pharmaceutical industry has been hiding this research for years.
Exposed men have suffered in silence — exhausted, embarrassed, watching their lives shrink around a bathroom schedule — while drug companies counted their billions.
Now you know the truth.
Don’t let them profit from your suffering one more day.
https://try.rootedvitalsmd.com/NewResearch
P.S. — They’ve known for decades that prostate problems are caused by suffocation, not “just aging” — and that natural compounds can fix the root cause in ways their drugs never will. They buried this research because it threatens their profits. But they can’t bury your results. FlowRevive contains all 10 compounds identified in the European research, at therapeutic dosages. The 90-day guarantee means you risk nothing. They’ve been profiting from your suffering long enough. It’s time to take your life back.
BREAKING STUDY: Pfizer mRNA Found in Over 88% of Human Placentas, Sperm, and Blood — and in 50% of Unvaccinated Pregnant Women by Nicolas Hulscher, MPH
Human biodistribution study shows Pfizer mRNA penetrates fetal and reproductive tissues, persists long-term in the body, and presents clear evidence of shedding.
For years, the public was told a simple story: the mRNA “stays in the arm,” degrades within hours, never enters the bloodstream, never crosses the placenta, never reaches the reproductive system, and certainly cannot be shed or transferred to others. These claims were repeated endlessly by agencies, fact-checkers, news outlets, and medical institutions, despite the fact that no long-term human biodistribution studies had ever been performed.
A new peer-reviewed study published in Annals of Case Reports titled, Detection of Pfizer BioNTech Messenger RNA COVID-19 Vaccine in Human Blood, Placenta and Semen, ends that narrative.
Researchers from Bar-Ilan University and several Israeli medical centers used nested PCR combined with Sanger sequencing—a far more sensitive and specific method than the standard qPCR used in earlier studies—to test for Pfizer mRNA in human tissues from 34 participants, including 22 pregnant women, 4 male sperm donors (8 samples), and 8 additional adults.
Their findings are deeply worrisome: 88% of pregnant women vaccinated within the last 100 days showed detectable Pfizer mRNA in both blood and placental tissue. Among male sperm donors, 100% of those who produced sperm had vaccine mRNA in their sperm cells, and 50% had it detectable in seminal fluid—long after vaccination.
Even more concerning, Pfizer mRNA was detected in 50% of the unvaccinated women tested —two in both placenta and blood, and one in blood alone; a result that forces the scientific community to confront the reality of shedding, something officials categorically deny.
Most striking of all, mRNA was still present in 50% of individuals more than 200 days after injection.
https://www.thefocalpoints.com/p/breaking-study-pfizer-mrna-found
STUDY: Common Vaccines Linked to 38-50% Increased Risk of Dementia and Alzheimer’s
The single largest vaccine–dementia study ever conducted (n=13.3 million) finds risk intensifies with more doses, remains elevated for a full decade, and is strongest after flu and pneumococcal shots.
The single largest and most rigorous study ever conducted on vaccines and dementia — spanning 13.3 million UK adults — has uncovered a deeply troubling pattern: those who received common adult vaccines faced a significantly higher risk of both dementia and Alzheimer’s disease.
The risk intensifies with more doses, remains elevated for a full decade, and is strongest after influenza and pneumococcal vaccination. With each layer of statistical adjustment, the signal doesn’t fade — it becomes sharper, more consistent, and increasingly difficult to explain away.
And critically, these associations persisted even after adjusting for an unusually wide range of potential confounders, including age, sex, socioeconomic status, BMI, smoking, alcohol-related disorders, hypertension, atrial fibrillation, heart failure, coronary artery disease, stroke/TIA, peripheral vascular disease, diabetes, chronic kidney and liver disease, depression, epilepsy, Parkinson’s disease, cancer, traumatic brain injury, hypothyroidism, osteoporosis, and dozens of medications ranging from NSAIDs and opioids to statins, antiplatelets, immunosuppressants, and antidepressants.
Even after controlling for this extensive list, the elevated risks remained strong and remarkably stable.
The vaccine does not stay in the arm.
Its products do not remain confined to the individual.
And the biological signals generated in response may behave in ways that resemble “spread,” even though no infectious agent is present.
https://open.substack.com/pub/petermcculloughmd/p/study-common-vaccines-linked-to-38
Ross Perot
His employees got thrown in an Iranian prison. He hired Special Forces to break them out.
A $1,000 investment created a man who almost became president.
Ross Perot was 32 years old.
He quit IBM in 1962. Started Electronic Data Systems with nothing but an idea and a thousand bucks.
Everyone said he was crazy.
“Why would you leave the best sales job in America?”
“Data processing? Nobody’s buying that.”
“You’re throwing away your career.”
He didn’t listen.
But here’s what nobody tells you. They were almost right.
Perot was rejected 77 times before landing his first contract.
Seventy-seven nos. Most people quit after five. Maybe ten.
He kept going.
By 1968, EDS went public. The stock opened at $16. Within days it hit $160.
Forbes called him “the fastest, richest Texan.”
By December 1969, his shares were worth $1 billion.
Then April 1970 happened.
In a single day, Perot lost $445 million on the stock exchange.
The biggest individual loss in NYSE history at that time.
Wall Street laughed. “The Texan got what was coming to him.”
Most people would have crumbled. Sold everything. Gone back to a safe job.
Perot? He just kept building.
Fourteen years later, he sold EDS to General Motors for $2.4 billion.
But that’s not what makes this story interesting.
In 1979, a young Bill Gates approached Perot about buying Microsoft. A tiny software company worth maybe $2 million.
Perot thought the asking price was too high.
He passed.
Microsoft is now worth over $3 trillion.
Perot called it “one of the biggest business mistakes I’ve ever made.”
But here’s what separates good entrepreneurs from great ones.
When Steve Jobs got fired from Apple in 1985, he started a new company called NeXT. Everyone said Jobs was finished. Washed up. A has-been at 30.
Perot watched a PBS documentary about Jobs. Called him the next morning.
“If you ever need an investor, call me.”
Perot invested $20 million into NeXT. Took a board seat.
He didn’t want to miss another Microsoft.
NeXT struggled. The computers didn’t sell. Most people would have written it off as a loss.
But in 1996, Apple bought NeXT for $400 million. Jobs came back.
NeXT’s software became the foundation for macOS. And later, the iPhone.
Perot’s “failed” investment helped create the most valuable company on Earth.
But he wasn’t done.
In 1979, two of his EDS employees were arrested in Iran during the revolution. The government wanted $12.7 million in ransom. The U.S. couldn’t help.
Most CEOs would have hired lawyers. Waited it out. Let bureaucracy run its course.
Perot hired a retired Special Forces colonel. Assembled a team of Vietnam veterans who worked for EDS. Flew to Tehran himself.
When negotiations failed, his team helped start a prison riot. 11,000 inmates escaped. Including his two employees.
They drove 500 miles overland to Turkey.
All of them made it home.
Hollywood made a miniseries about it. Ken Follett wrote a bestseller.
Then came politics.
In 1992, Perot announced he was running for president. As an independent. No party. No political machine.
Everyone said it was impossible.
“Third-party candidates never win.”
“He’s wasting his money.”
“Americans don’t vote independent.”
At one point, Perot led the polls. Ahead of both George Bush and Bill Clinton.
He dropped out in July. Came back in October.
Still got nearly 20 million votes. 19% of the popular vote.
The most successful third-party candidate since Theodore Roosevelt in 1912.
He changed how campaigns worked. Used TV infomercials instead of rallies. Spoke directly to voters on talk shows. No handlers. No scripts.
He ran again in 1996. Got 8% of the vote.
Never won an election. Never held office.
But here’s what people miss.
Perot didn’t run to win. He ran to prove a point. That ordinary Americans were tired of being ignored. That you didn’t need permission from the political establishment to have a voice.
When he died in 2019, he was worth $4.1 billion.
Started with $1,000.
Rejected 77 times.
Lost $445 million in a single day.
Missed Microsoft.
Got called crazy for running for president.
Still built companies that sold for billions. Still rescued his people from a foreign prison. Still changed American politics. Still helped fund the technology that powers every iPhone on the planet.
What rejection are you letting stop you?
What “failure” are you treating like the end?
Perot got rejected 77 times before his first yes.
He lost almost half a billion dollars in one day and kept going.
He missed the biggest investment opportunity in tech history and still funded the next one.
He ran for president twice without winning and still made history.
Stop counting your losses.
Start counting your attempts.
The guy who got told no 77 times built a multi-billion dollar empire, bankrolled the iPhone, and ran for president.
Your “impossible” goal doesn’t look so impossible anymore, does it?
Think Big.